Engineering tandem <scp>VHHs</scp> to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity
Yuqiang Xu(Nanotherapeutics (United States)), Mark L. Chiu(Gwynedd Council)
Cited by 0
Related Papers
A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
|Frontiers in Oncology|2025|7
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs
|Pharmaceutics|2025|7
Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer Models
|Cancers|2025|6
Large scale controlled Fab exchange GMP process to prepare bispecific antibodies
|Frontiers in Bioengineering and Biotechnology|2024|5
A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function
|Biochemistry|2024|5